12.22
Schlusskurs vom Vortag:
$12.04
Offen:
$12.01
24-Stunden-Volumen:
369.59K
Relative Volume:
0.80
Marktkapitalisierung:
$421.85M
Einnahmen:
$90.44M
Nettoeinkommen (Verlust:
$561.00K
KGV:
2,036.67
EPS:
0.006
Netto-Cashflow:
$19.19M
1W Leistung:
+0.00%
1M Leistung:
-2.94%
6M Leistung:
+23.31%
1J Leistung:
+13.67%
Delcath Systems Inc Stock (DCTH) Company Profile
Firmenname
Delcath Systems Inc
Sektor
Branche
Telefon
(518) 743-8892
Adresse
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
DCTH
Delcath Systems Inc
|
12.22 | 412.19M | 90.44M | 561.00K | 19.19M | 0.006 |
|
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-28 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-14 | Eingeleitet | Stephens | Overweight |
| 2022-07-26 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-03-09 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-01-05 | Eingeleitet | BTIG Research | Buy |
| 2020-06-01 | Eingeleitet | Laidlaw | Buy |
Alle ansehen
Delcath Systems Inc Aktie (DCTH) Neueste Nachrichten
DCTH|Delcath Systems Inc|Price:11.960|Chg%:-0.260 - TradingKey
Delcath Systems Inc (DCTH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
DCTH|Delcath Systems Inc|Price:12.150|Chg%:-0.070 - TradingKey
Delcath Systems Inc (DCTH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Delcath Systems Inc (DCTH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Delcath Systems Inc (DCTH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Delcath Systems Inc (DCTH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Delcath Systems Inc (DCTH) Cash Flow - TradingKey
Delcath Systems Inc (DCTH) Income Statement - TradingKey
Delcath Systems, Inc. Revenue Breakdown – LS:A2PT5P - TradingView
Delcath Systems Inc (DCTH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Press Release: Delcath Systems to Host Second Quarter 2026 Earnings Call - Moomoo
Delcath Systems sets Aug. 6 briefing on second-quarter results - Stock Titan
Understanding Momentum Shifts in (DCTH) - Stock Traders Daily
Delcath Systems schedules second-quarter 2026 earnings call - Bitget
Delcath Systems announces inducement grants - Medical Buyer
ETFs Investing in Delcath Systems, Inc. Stocks - TradingView
Four Delcath Employees Receive Stock Awards Tied to Vesting Dates - Stock Titan
Delcath Systems (DCTH) Slides 3.77% as Stock Tests Key Support LevelsFlat Correction - dars.gov.et
Is Delcath Systems Inc (DCTH) a Bargain After 3.8% Drop? GF Value Says Undervalued - GuruFocus
CCORF Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $21 - Moomoo
Delcath Systems begins Phase 2 breast cancer trial - grafa.com
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer - BioSpace
Delcath doses first patient in breast cancer trial in Milan By Investing.com - Investing.com Nigeria
Delcath doses first patient in breast cancer trial in Milan - Investing.com
$13.513 | Delcath Systems, Inc. Common Stock (DCTH) Stock Price Today - Binance
Delcath Systems (DCTH) Gains 2.12% as Stock Approaches Key Resistance LevelGEX Level - DonanımHaber
DCTH Q1 2026 Earnings: EPS Surprises to the Upside as Company Advances Core PipelineEarnings Per Share - dars.gov.et
DCTHDelcath Systems Inc Options - Finviz
Price to sales forward of Delcath Systems, Inc. – NASDAQ:DCTH - TradingView
Avoiding Lag: Real-Time Signals in (DCTH) Movement - Stock Traders Daily
Delcath Systems, Inc.(NasdaqCM:DCTH) added to Russell Microcap Value Benchmark Index - marketscreener.com
Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2000 Value Benchmark - marketscreener.com
Price to book forward of Delcath Systems, Inc. – SWB:DV3R - TradingView
Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2000 Value-Defensive Index - marketscreener.com
Price to earnings forward of Delcath Systems, Inc. – NASDAQ:DCTH - TradingView
Enterprise value to revenue forward of Delcath Systems, Inc. – SWB:DV3R - TradingView
Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 3000 Value Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Delcath Systems, Inc. – NASDAQ:DCTH - TradingView
Mettler-Toledo (MTD) soars 3.3%: Is further upside left in the stock? - MSN
Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2000 Defensive Index - marketscreener.com
Delcath Systems, Inc. Actuals & Estimates (FWB:DV3R) - TradingView
Delcath Systems, Inc. Actuals & Estimates (NASDAQ:DCTH) - TradingView
Delcath Systems, Inc. Actuals & Estimates (LS:A2PT5P) - TradingView
DCTH Forecast — Price Target — Prediction for 2027 - TradingView
Delcath Systems Inc (DCTH) Institutional Confidence - TradingKey
Delcath Systems (DCTH) Surges 5.6% on Above-Average Volume, Tests Key ResistanceChart Pattern Alerts - dars.gov.et
Delcath Systems, Inc. (DCTH) reports Q1 loss, misses revenue estimates - MSN
Delcath Systems Inc (DCTH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Delcath Systems (DCTH) Dips 2% as Stock Approaches Critical SupportHigh Volume Stocks - dars.gov.et
Delcath Systems Inc (DCTH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Finanzdaten der Delcath Systems Inc-Aktie (DCTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Delcath Systems Inc-Aktie (DCTH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sylvester John Richard | Director |
Nov 21 '25 |
Buy |
8.89 |
4,386 |
38,992 |
14,936 |
| MICHEL GERARD J | CHIEF EXECUTIVE OFFICER |
Nov 11 '25 |
Buy |
8.53 |
11,500 |
98,049 |
330,834 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):